In July, there were important developments in the field of ageing research and treatments that can improve the quality and duration of life. Among other things, scientists investigated how inflammation plays a role in ageing and how certain medicines extend the lifespan of laboratory animals. It has also become clear that some experimental therapies carry risks, such as a recent death following an untested treatment in New York.
A striking research direction focuses on combining anti-inflammatory agents with stem cell therapy. In animal studies, this combination appears to promote tissue repair, which holds promise for future applications in humans. In addition, new insights show that regular and targeted exercise can counteract muscle ageing and that nutrition, for example through fasting, can have a positive impact on lifespan.
Alongside scientific advancements, there are also discussions about adapting health guidelines. For instance, researchers are advocating for increasing the recommended amounts of physical activity and protein intake to achieve optimal health, rather than just the minimum necessary standards. This aligns with the growing focus on prevention and the maintenance of vitality in later life.
Research into biological ageing clocks, which measure biological age, is also growing. These clocks help to better understand how the body ages and which treatments actually have an effect. At the same time, it is emphasised that caution is required with new and as yet unproven therapies. The death following the NAD⁺ infusion underscores the need for strict controls and reliable data before treatments are widely introduced.
These developments are of great importance to anyone who wants to age in a healthy way. Through a better understanding of ageing processes and new treatment methods, we may be able to remain vital for longer in the future.
Source: Editorial
